annual CFO:
$224.80M-$5.59B(-96.13%)Summary
- As of today (May 29, 2025), BNTX annual cash flow from operations is $224.80 million, with the most recent change of -$5.59 billion (-96.13%) on December 31, 2024.
- During the last 3 years, BNTX annual CFO has fallen by -$827.87 million (-78.64%).
- BNTX annual CFO is now -98.43% below its all-time high of $14.32 billion, reached on December 31, 2022.
Performance
BNTX Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$821.48M-$308.31M(-60.08%)Summary
- As of today (May 29, 2025), BNTX quarterly cash flow from operations is -$821.48 million, with the most recent change of -$308.31 million (-60.08%) on March 1, 2025.
- Over the past year, BNTX quarterly CFO has dropped by -$476.83 million (-138.35%).
- BNTX quarterly CFO is now -117.21% below its all-time high of $4.77 billion, reached on June 30, 2023.
Performance
BNTX quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$252.02M-$476.83M(-212.11%)Summary
- As of today (May 29, 2025), BNTX TTM cash flow from operations is -$252.02 million, with the most recent change of -$476.83 million (-212.11%) on March 1, 2025.
- Over the past year, BNTX TTM CFO has dropped by -$6.45 billion (-104.07%).
- BNTX TTM CFO is now -101.76% below its all-time high of $14.32 billion, reached on December 31, 2022.
Performance
BNTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
BNTX Cash from operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -96.1% | -138.3% | -104.1% |
3 y3 years | -78.6% | -118.1% | -104.2% |
5 y5 years | +201.2% | -1260.9% | -2.0% |
BNTX Cash from operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -98.4% | at low | -117.2% | at low | -101.8% | at low |
5 y | 5-year | -98.4% | +201.2% | -117.2% | at low | -101.8% | +42.0% |
alltime | all time | -98.4% | +201.2% | -117.2% | at low | -101.8% | +42.0% |
BNTX Cash from operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$821.48M(+60.1%) | -$252.02M(-212.1%) |
Dec 2024 | $224.80M(-96.1%) | -$513.17M(-23.7%) | $224.80M(-86.2%) |
Sep 2024 | - | -$672.46M(-138.3%) | $1.63B(-48.7%) |
Jun 2024 | - | $1.76B(-609.2%) | $3.18B(-48.7%) |
Mar 2024 | - | -$344.65M(-138.6%) | $6.20B(+6.6%) |
Dec 2023 | $5.82B(-59.4%) | $893.27M(+1.8%) | $5.82B(-9.1%) |
Sep 2023 | - | $877.10M(-81.6%) | $6.40B(-35.2%) |
Jun 2023 | - | $4.77B(-755.9%) | $9.87B(+9.2%) |
Mar 2023 | - | -$727.55M(-149.3%) | $9.05B(-36.8%) |
Dec 2022 | $14.32B(+1260.2%) | $1.48B(-66.1%) | $14.32B(+13.5%) |
Sep 2022 | - | $4.35B(+10.4%) | $12.61B(+25.6%) |
Jun 2022 | - | $3.94B(-13.2%) | $10.04B(+68.1%) |
Mar 2022 | - | $4.54B(-2062.7%) | $5.97B(+467.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $1.05B(-6927.8%) | -$231.55M(-113.0%) | $1.05B(-33.2%) |
Sep 2021 | - | $1.78B(-1572.2%) | $1.58B(-463.0%) |
Jun 2021 | - | -$120.93M(-67.8%) | -$434.16M(+31.5%) |
Mar 2021 | - | -$375.12M(-228.6%) | -$330.18M(+2041.6%) |
Dec 2020 | -$15.42M(-93.1%) | $291.78M(-226.9%) | -$15.42M(-95.9%) |
Sep 2020 | - | -$229.89M(+1256.4%) | -$379.41M(+86.7%) |
Jun 2020 | - | -$16.95M(-71.9%) | -$203.27M(-17.7%) |
Mar 2020 | - | -$60.36M(-16.4%) | -$247.12M(+11.2%) |
Dec 2019 | -$222.22M(+219.6%) | -$72.21M(+34.4%) | -$222.22M(+48.1%) |
Sep 2019 | - | -$53.75M(-11.6%) | -$150.01M(+55.8%) |
Jun 2019 | - | -$60.80M(+71.5%) | -$96.26M(+171.5%) |
Mar 2019 | - | -$35.46M | -$35.46M |
Dec 2018 | -$69.52M(+16.8%) | - | - |
Dec 2017 | -$59.53M | - | - |
FAQ
- What is BioNTech SE annual cash flow from operations?
- What is the all time high annual CFO for BioNTech SE?
- What is BioNTech SE annual CFO year-on-year change?
- What is BioNTech SE quarterly cash flow from operations?
- What is the all time high quarterly CFO for BioNTech SE?
- What is BioNTech SE quarterly CFO year-on-year change?
- What is BioNTech SE TTM cash flow from operations?
- What is the all time high TTM CFO for BioNTech SE?
- What is BioNTech SE TTM CFO year-on-year change?
What is BioNTech SE annual cash flow from operations?
The current annual CFO of BNTX is $224.80M
What is the all time high annual CFO for BioNTech SE?
BioNTech SE all-time high annual cash flow from operations is $14.32B
What is BioNTech SE annual CFO year-on-year change?
Over the past year, BNTX annual cash flow from operations has changed by -$5.59B (-96.13%)
What is BioNTech SE quarterly cash flow from operations?
The current quarterly CFO of BNTX is -$821.48M
What is the all time high quarterly CFO for BioNTech SE?
BioNTech SE all-time high quarterly cash flow from operations is $4.77B
What is BioNTech SE quarterly CFO year-on-year change?
Over the past year, BNTX quarterly cash flow from operations has changed by -$476.83M (-138.35%)
What is BioNTech SE TTM cash flow from operations?
The current TTM CFO of BNTX is -$252.02M
What is the all time high TTM CFO for BioNTech SE?
BioNTech SE all-time high TTM cash flow from operations is $14.32B
What is BioNTech SE TTM CFO year-on-year change?
Over the past year, BNTX TTM cash flow from operations has changed by -$6.45B (-104.07%)